Monday, 2 June 2025

Avalon Pharma Transfers SAR 25.2 mln Statutory Reserve to Retained Earnings

اقرأ المزيد

Middle East Pharmaceutical Industries (Avalon Pharma) said on Sunday that shareholders approved the transfer of SAR 25.2 million in statutory reserves to retained earnings during its Extraordinary General Assembly Meeting.

The reclassification relates to the balance reported in Avalon’s audited financial statements for the year ended Dec. 31, 2024, the company said in a statement.

Related





Articles